TRILURON Trademark

Trademark Overview


On Thursday, November 29, 2018, a trademark application was filed for TRILURON with the United States Patent and Trademark Office. The USPTO has given the TRILURON trademark a serial number of 79257832. The federal status of this trademark filing is REGISTERED as of Tuesday, January 28, 2020. This trademark is owned by FIDIA FARMACEUTICI S.p.A.. The TRILURON trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceuticals and medical preparations for the treatment of the joints, for traumatic and degenerative joint pathologies and for use during orthopedic surgery; pharmaceutical preparations for the treatment of rheumatologic diseases; analgesic preparations; pharmaceutical preparations for the treatment of diseases of the muscular and skeletal system; pre-filled syringes for medical use filled with analgesic preparations, preparations for the treatment of the joints, for traumatic and degenerative joint pathologies, for use during orthopedic surgery, for the treatment of rheumatologic diseases and for the treatment of diseases of the muscular and skeletal system

Medical syringes; cannulae; applicators and medical devices for the administration of pharmaceutical preparations, namely injection devices for pharmaceuticals and medical preparations; medico-surgical devices for the treatment of degenerative and traumatic joints and musculoskeletal apparatus and for use during orthopedic surgery
triluron

General Information


Serial Number79257832
Word MarkTRILURON
Filing DateThursday, November 29, 2018
Status700 - REGISTERED
Status DateTuesday, January 28, 2020
Registration Number5969841
Registration DateTuesday, January 28, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements


Goods and ServicesPharmaceuticals and medical preparations for the treatment of the joints, for traumatic and degenerative joint pathologies and for use during orthopedic surgery; pharmaceutical preparations for the treatment of rheumatologic diseases; analgesic preparations; pharmaceutical preparations for the treatment of diseases of the muscular and skeletal system; pre-filled syringes for medical use filled with analgesic preparations, preparations for the treatment of the joints, for traumatic and degenerative joint pathologies, for use during orthopedic surgery, for the treatment of rheumatologic diseases and for the treatment of diseases of the muscular and skeletal system
Goods and ServicesMedical syringes; cannulae; applicators and medical devices for the administration of pharmaceutical preparations, namely injection devices for pharmaceuticals and medical preparations; medico-surgical devices for the treatment of degenerative and traumatic joints and musculoskeletal apparatus and for use during orthopedic surgery

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, May 6, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFIDIA FARMACEUTICI S.p.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameFIDIA FARMACEUTICI S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameFIDIA FARMACEUTICI S.p.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressIT

Trademark Events


Event DateEvent Description
Friday, May 29, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 11, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 11, 2020FINAL DISPOSITION PROCESSED
Tuesday, April 28, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 6, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, February 7, 2020NOTIFICATION PROCESSED BY IB
Thursday, January 30, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, January 28, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 23, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 10, 2019ASSIGNED TO LIE
Monday, October 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 22, 2019REFUSAL PROCESSED BY IB
Sunday, June 2, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, June 2, 2019REFUSAL PROCESSED BY MPU
Friday, May 10, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, May 7, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 6, 2019NON-FINAL ACTION WRITTEN
Monday, May 6, 2019ASSIGNED TO EXAMINER
Monday, May 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 2, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB